Anika Therapeutics buy Barrington Research
Start price
22.10.24
/
50%
€22.80
Target price
22.10.25
€34.22
Performance (%)
-69.30%
Price
11.08.25
€6.90
Summary
This prediction is currently active. Massive losses of -69.30% have been the result for the BUY prediction by Barrington_Research. This prediction currently runs until 22.10.25. The prediction end date can be changed by Barrington_Research at any time. Barrington_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Anika Therapeutics | -5.405% | -5.405% |
| iShares Core DAX® | 1.217% | -0.632% |
| iShares Nasdaq 100 | 1.220% | 4.085% |
| iShares Nikkei 225® | 3.599% | 7.023% |
| iShares S&P 500 | 0.462% | 2.682% |
Comments by Barrington_Research for this prediction
In the thread Anika Therapeutics diskutieren
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $37.00 price target on the stock.
Ratings data for ANIK provided by MarketBeat
Stopped prediction by Barrington_Research for Anika Therapeutics
Anika Therapeutics
Start price
Target price
Perf. (%)
€7.15
31.07.25
31.07.25
€13.12
31.07.26
31.07.26
-3.50%
11.08.25
11.08.25
Anika Therapeutics
Start price
Target price
Perf. (%)
€10.60
12.05.25
12.05.25
€16.93
12.05.26
12.05.26
-34.91%
11.08.25
11.08.25
Anika Therapeutics
Start price
Target price
Perf. (%)
€14.80
13.03.25
13.03.25
€18.37
13.03.26
13.03.26
-53.38%
11.08.25
11.08.25
Anika Therapeutics
Start price
Target price
Perf. (%)
€15.40
01.11.24
01.11.24
€23.03
01.11.25
01.11.25
-55.19%
11.08.25
11.08.25
Anika Therapeutics
Start price
Target price
Perf. (%)
€23.40
09.05.24
09.05.24
€34.32
09.05.25
09.05.25
-55.56%
10.05.25
10.05.25
Anika Therapeutics
Start price
Target price
Perf. (%)
€20.60
03.01.24
03.01.24
€26.58
03.01.25
03.01.25
-23.79%
04.01.25
04.01.25
Anika Therapeutics
Start price
Target price
Perf. (%)
€19.70
03.11.23
03.11.23
€26.08
03.11.24
03.11.24
-23.35%
04.11.24
04.11.24